Sen, S. “Canagliflozin (Invokana®): A First-in-Class Anti-Diabetic Drug”. Journal of Drug Delivery and Therapeutics, Vol. 3, no. 3, May 2013, pp. 145-6, doi:10.22270/jddt.v3i3.490.